NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Truveta

Truveta

Private
Bellevue, WashingtonHealthcare & Life Scienceshttps://www.truveta.com/

Last Round

Series C

Jan 13, 2025

Est. Valuation

$1B

Total Funding Raised

$620M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Truveta is a health technology company that provides a platform for aggregating and de-identifying electronic health record data to support medical research and clinical decision-making.

Sector

Healthcare & Life Sciences

Verticals

Healthcare Analytics, EHR & EMR, Clinical Trials, Drug Discovery, Medical AI

Business Model

B2B

Customer Profile

Data as a Service, Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

electronic health recordEHRreal-world evidenceclinical data platformhealth data analyticsmedical researchdata as a serviceDaaSdrug developmentclinical insightshealthcare AImedical AIlongitudinal patient datagenomic datahealth data lakeclinical research toolhealth tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Truveta Comparables

Compare Truveta with similar companies based on industry and business-model similarity.

Truveta comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
nference
86%
Verana Health
85%
Komodo Health
84%

Truveta Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CJan 13, 2025
Series BNov 9, 2021
Series A ExtensionSep 29, 2021
Series AJul 13, 2021

Key People

Founding team and executive leadership

Jay Nanduri

Chief Technical Officer Co-Founder

Founding Team

Ryan Ahern

Chief Medical Officer Co-founder

Founding Team

Terry Myerson

CEO and Co-founder

Founding Team

Truveta Investors

Notable investors and investment history

Truveta investors
InvestorRounds
Ochsner VenturesSeries B
Catholic Health InitiativesSeries A, Series C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 23, 2026

    Job posting discloses an ISO 27018 certification extension.

  • Apr 23, 2026

    Achieved HITRUST r2 certification for data security.

Truveta Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Truveta Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Truveta's valuation, stock price, and market status.

Firmographic Details

HeadquartersBellevue, Washington
Employee Range443
Year Founded2020
Last FundingJan 13, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.